Piramal Pharma Solutions announces acquisition of solid oral dosage drug product facility in Sellersville, Pennsylvania from G&W Laboratories

This article was originally published here

The transaction closure is subject to customary pre-closing conditions. According to the terms of the agreement, PEL, through one of its Affiliates, would acquire at closing a 100%

The post Piramal Pharma Solutions announces acquisition of solid oral dosage drug product facility in Sellersville, Pennsylvania from G&W Laboratories appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply